January 3, 2018 / 9:24 PM / 6 months ago

BRIEF-Ovascience Says ‍Reducing Headcount By Approximately 50 Percent​

Jan 3 (Reuters) - Ovascience Inc:

* OVASCIENCESM ANNOUNCES CORPORATE UPDATE

* OVASCIENCE INC - ‍REDUCING HEADCOUNT BY APPROXIMATELY 50 PERCENT​

* OVASCIENCE INC - ‍MAJORITY OF REDUCTION IN PERSONNEL IS EXPECTED TO BE COMPLETED BY MARCH 2018​

* OVASCIENCE INC - JAMES LILLIE JOINING AS CHIEF SCIENTIFIC OFFICER

* OVASCIENCE INC - ‍AS A RESULT OF REDUCTION IN PERSONNEL, CO EXPECTS TO REALIZE ANNUALIZED COST SAVINGS BEGINNING IN Q2 OF 2018​

* OVASCIENCE INC - ‍ESTIMATES THAT IT WILL INCUR ONE-TIME COSTS OF APPROXIMATELY $1.0 MILLION TO $1.5 MILLION RELATED TO RESTRUCTURING PLAN​

* OVASCIENCE INC - ‍PLANS TO INITIATE A MULTI-CENTER, PROSPECTIVE, CONTROLLED, PHASE 1B/2A CLINICAL TRIAL OF OVAPRIME​

* OVASCIENCE INC - ‍EXPECTS TO BEGIN PATIENT ENROLLMENT IN FIRST HALF OF 2018 AND TO REPORT INITIAL CLINICAL DATA IN 2019​ FROM PLANNED OVAPRIME TRIAL Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below